Gary Charles Robb - 04 Dec 2023 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Signature
/s/ Joseph Douglas Lyon, as attorney-in-fact for Gary Charles Robb.
Issuer symbol
CORT
Transactions as of
04 Dec 2023
Net transactions value
-$385,486
Form type
4
Filing time
06 Dec 2023, 20:56:23 UTC
Previous filing
05 Dec 2023
Next filing
12 Dec 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CORT Common Stock Options Exercise $49,350 +15,000 +66% $3.29* 37,771 04 Dec 2023 Direct F1
transaction CORT Common Stock Tax liability $230,773 -8,788 -23% $26.26 28,983 04 Dec 2023 Direct F1, F2
transaction CORT Common Stock Sale $36,277 -1,381 -4.8% $26.27 27,602 05 Dec 2023 Direct F1
transaction CORT Common Stock Sale $167,786 -6,212 -23% $27.01 21,390 06 Dec 2023 Direct F1
holding CORT Common Stock 8,061 04 Dec 2023 Custodial Account for Child F3
holding CORT Common Stock 8,061 04 Dec 2023 Custodial Account for Child F3
holding CORT Common Stock 8,061 04 Dec 2023 Custodial Account for Child F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CORT Stock option (right to buy) Options Exercise $0 -15,000 -20% $0.000000 61,037 04 Dec 2023 Common Stock 15,000 $3.29 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 1,600 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023, 2,091 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023, and 500 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.
F2 These shares were withheld so the Reporting Person could satisfy the exercise price and tax liability arising from a net (cashless) exercise of stock options that occurred on December 4, 2023. The options subject to the net exercise were to expire on February 18, 2025.
F3 These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian.
F4 Fully exercisable.

Remarks:

The power of attorney under which this form was signed is on file with the Commission.